4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001209191-18-021896
Chief Financial Officer acquired 59 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Payne Fletcher · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-03-26 | Exercise or conversion : show line 1 in the form | +59 | $4.63 | $273 | 59 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-03-26 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −59 | $4.63 | 2027-07-11 | 59 | 74,941 | D |
Loading xslF345X03/doc4.xml…